Kissei Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Kissei Pharmaceutical has a total shareholder equity of ¥220.8B and total debt of ¥1.3B, which brings its debt-to-equity ratio to 0.6%. Its total assets and total liabilities are ¥260.3B and ¥39.6B respectively. Kissei Pharmaceutical's EBIT is ¥3.8B making its interest coverage ratio -2.9. It has cash and short-term investments of ¥50.0B.
Key information
0.6%
Debt to equity ratio
JP¥1.26b
Debt
| Interest coverage ratio | -2.9x |
| Cash | JP¥49.96b |
| Equity | JP¥220.77b |
| Total liabilities | JP¥39.57b |
| Total assets | JP¥260.34b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: KSPH.F's short term assets (¥107.0B) exceed its short term liabilities (¥19.4B).
Long Term Liabilities: KSPH.F's short term assets (¥107.0B) exceed its long term liabilities (¥20.1B).
Debt to Equity History and Analysis
Debt Level: KSPH.F has more cash than its total debt.
Reducing Debt: KSPH.F's debt to equity ratio has reduced from 2% to 0.6% over the past 5 years.
Debt Coverage: KSPH.F's debt is well covered by operating cash flow (272.3%).
Interest Coverage: KSPH.F earns more interest than it pays, so coverage of interest payments is not a concern.